In Another regulatory milestone, Aubagio® (Teriflunomide) was approved by the European Commission (EC) for use in the treatment of Relapsing Multiple Sclerosis (RMS).
For more info on Aubagio and Mutliple Scelrosis please click on the below link:
We use cookies to ensure that we give you the best experience on our website. You agree to the use of cookies by closing this banner, by scrolling this page, by clicking a link or by continuing to browse otherwise.OkCookies Policy
